MRI/MRS in neuroinflammation: methodology and applications

Neuroinflammation encompasses a wide range of humoral and cellular responses, not only enabling the CNS to fight various noxious events, including infections and trauma, but also playing a critical role in autoimmune as well as in neurodegenerative diseases. The complex interactions of immune, endothelial, and neuronal cells that take place during inflammation require an equivalent complexity of imaging approaches to be appropriately explored in vivo. Magnetic Resonance provides several complementary techniques that allow to study most mechanisms underlying the brain/immune interaction. In this review, we discuss the MR approaches to the study of endothelial activation, blood–brain barrier permeability alterations, intercellular compartment modifications, immune cell trafficking, and of metabolic alterations linked to immune cell activity. The main advantages and limitations of these techniques are assessed, in view of their exploitation in the clinical arena, where the complementarity of the information that can be obtained has the potential to change our way of studying neuroinflammation, with implications for the management of several CNS diseases.

[1]  Bruce R. Rosen,et al.  Increased in vivo glial activation in patients with amyotrophic lateral sclerosis: Assessed with [11C]-PBR28 , 2015, NeuroImage: Clinical.

[2]  Aaron J. Johnson,et al.  In vivo magnetic resonance imaging of immune cells in the central nervous system with superparamagnetic antibodies , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[3]  Ben A. Duffy,et al.  Imaging seizure-induced inflammation using an antibody targeted iron oxide contrast agent , 2012, NeuroImage.

[4]  P. Styles,et al.  Hypo‐osmotic swelling‐activated release of organic osmolytes in brain slices: implications for brain oedema in vivo , 2001, Journal of neurochemistry.

[5]  M. Rausch,et al.  In‐vivo visualization of phagocytotic cells in rat brains after transient ischemia by USPIO , 2002, NMR in biomedicine.

[6]  Andreas Saleh,et al.  In vivo MRI of brain in ̄ ammation in human ischaemic stroke , 2004 .

[7]  D. Leibfritz,et al.  Multinuclear NMR studies on the energy metabolism of glial and neuronal cells. , 1993, Developmental neuroscience.

[8]  N. Sibson,et al.  VCAM‐1‐targeted magnetic resonance imaging reveals subclinical disease in a mouse model of multiple sclerosis , 2011, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[9]  Brian K Rutt,et al.  Detection threshold of single SPIO‐labeled cells with FIESTA , 2005, Magnetic resonance in medicine.

[10]  M. Inglese,et al.  Diffusion imaging in multiple sclerosis: research and clinical implications , 2010 .

[11]  J. Smirniotopoulos,et al.  Patterns of contrast enhancement in the brain and meninges. , 2007, Radiographics : a review publication of the Radiological Society of North America, Inc.

[12]  J. Bernarding,et al.  Metabolic changes in the vicinity of brain contusions: a proton magnetic resonance spectroscopy and histology study. , 2003, Journal of neurotrauma.

[13]  Ting-Yim Lee,et al.  An Adiabatic Approximation to the Tissue Homogeneity Model for Water Exchange in the Brain: I. Theoretical Derivation , 1998, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[14]  R. Ransohoff,et al.  Inflammatory cell trafficking across the blood–brain barrier: chemokine regulation and in vitro models , 2012, Immunological reviews.

[15]  T. Koh,et al.  Phenotypic transitions of macrophages orchestrate tissue repair. , 2013, The American journal of pathology.

[16]  G. Réus,et al.  The role of inflammation and microglial activation in the pathophysiology of psychiatric disorders , 2015, Neuroscience.

[17]  S. Dhaliwal,et al.  Blood–brain barrier dysfunction developed during normal aging is associated with inflammation and loss of tight junctions but not with leukocyte recruitment , 2015, Immunity & Ageing.

[18]  H. Critchley,et al.  Quantitative Magnetization Transfer Imaging as a Biomarker for Effects of Systemic Inflammation on the Brain , 2015, Biological Psychiatry.

[19]  Tilman Grune,et al.  Iron oxide particles for molecular magnetic resonance imaging cause transient oxidative stress in rat macrophages. , 2004, Free radical biology & medicine.

[20]  E. Lo,et al.  Junctional complexes of the blood–brain barrier: permeability changes in neuroinflammation , 2002, Progress in Neurobiology.

[21]  J. Sandkühler,et al.  Neurogenic neuroinflammation: inflammatory CNS reactions in response to neuronal activity , 2013, Nature Reviews Neuroscience.

[22]  N. Intrator,et al.  Free water elimination and mapping from diffusion MRI , 2009, Magnetic resonance in medicine.

[23]  Jurgen E Schneider,et al.  In vivo magnetic resonance imaging of acute brain inflammation using microparticles of iron oxide , 2007, Nature Medicine.

[24]  L. Kappos,et al.  MR Imaging in Multiple Sclerosis: Review and Recommendations for Current Practice , 2010, American Journal of Neuroradiology.

[25]  Grace Hu,et al.  Molecular MR imaging of melanoma angiogenesis with ανβ3‐targeted paramagnetic nanoparticles , 2005, Magnetic resonance in medicine.

[26]  L. Steinman Blocking adhesion molecules as therapy for multiple sclerosis: natalizumab , 2005, Nature Reviews Drug Discovery.

[27]  D. Le Bihan,et al.  Diffusion tensor imaging: Concepts and applications , 2001, Journal of magnetic resonance imaging : JMRI.

[28]  Shigeru Furui,et al.  Gadolinium-based Contrast Agent Accumulates in the Brain Even in Subjects without Severe Renal Dysfunction: Evaluation of Autopsy Brain Specimens with Inductively Coupled Plasma Mass Spectroscopy. , 2015, Radiology.

[29]  H. Petropoulos,et al.  Metabolic and cognitive response to human traumatic brain injury: a quantitative proton magnetic resonance study. , 2000, Journal of neurotrauma.

[30]  T. Patterson,et al.  Elevated myo-inositol in gray matter of recently detoxified but not long-term abstinent alcoholics: a preliminary MR spectroscopy study. , 2000, Alcoholism, clinical and experimental research.

[31]  R. Lucht,et al.  Microcirculation and microvasculature in breast tumors: Pharmacokinetic analysis of dynamic MR image series , 2004, Magnetic resonance in medicine.

[32]  Joanna M. Wardlaw,et al.  Assessment of blood–brain barrier disruption using dynamic contrast-enhanced MRI. A systematic review , 2014, NeuroImage: Clinical.

[33]  A. Thompson,et al.  Elevated white matter myo-inositol in clinically isolated syndromes suggestive of multiple sclerosis. , 2004, Brain : a journal of neurology.

[34]  R. Henkelman,et al.  Magnetization transfer in MRI: a review , 2001, NMR in biomedicine.

[35]  V. Perry,et al.  Detection of the inhibitory neurotransmitter GABA in macrophages by magnetic resonance spectroscopy , 2005, Journal of leukocyte biology.

[36]  Frederik Barkhof,et al.  Pluriformity of inflammation in multiple sclerosis shown by ultra-small iron oxide particle enhancement. , 2008, Brain : a journal of neurology.

[37]  Carl-Fredrik Westin,et al.  The extent of diffusion MRI markers of neuroinflammation and white matter deterioration in chronic schizophrenia , 2015, Schizophrenia Research.

[38]  C Delalande,et al.  Comparison of ultrasmall particles of iron oxide (USPIO)-enhanced T2-weighted, conventional T2-weighted, and gadolinium-enhanced T1-weighted MR images in rats with experimental autoimmune encephalomyelitis. , 1999, AJNR. American journal of neuroradiology.

[39]  M. Yamada,et al.  Migration of enhanced green fluorescent protein expressing bone marrow-derived microglia/macrophage into the mouse brain following permanent focal ischemia , 2003, Neuroscience.

[40]  B. Tombach,et al.  Hepatic MRI with SPIO: detection and characterization of focal liver lesions , 1998, European Radiology.

[41]  A. Wong,et al.  Assessment of vessel permeability by combining dynamic contrast‐enhanced and arterial spin labeling MRI , 2015, NMR in biomedicine.

[42]  Richard C. Semelka,et al.  High Signal Intensity in Globus Pallidus and Dentate Nucleus on Unenhanced T1-weighted MR Images: Evaluation of Two Linear Gadolinium-based Contrast Agents. , 2015, Radiology.

[43]  Atle Bjørnerud,et al.  The utility of superparamagnetic contrast agents in MRI: theoretical consideration and applications in the cardiovascular system , 2004, NMR in biomedicine.

[44]  Joanna Wardlaw,et al.  Blood–brain barrier permeability in Alzheimer's disease: a case–control MRI study , 2009, Psychiatry Research: Neuroimaging.

[45]  P. Basser,et al.  Diffusion tensor MR imaging of the human brain. , 1996, Radiology.

[46]  E. Akbudak,et al.  Encoding of anisotropic diffusion with tetrahedral gradients: A general mathematical diffusion formalism and experimental results , 1996, Magnetic resonance in medicine.

[47]  W. Rooney,et al.  MR Imaging of Inflammation during Myelin-Specific T Cell-Mediated Autoimmune Attack in the EAE Mouse Spinal Cord , 2010, Molecular Imaging and Biology.

[48]  S. Pluchino,et al.  The role of the immune system in central nervous system plasticity after acute injury , 2014, Neuroscience.

[49]  P. Basser,et al.  Water Diffusion Changes in Wallerian Degeneration and Their Dependence on White Matter Architecture , 2000 .

[50]  Damien Galanaud,et al.  (1)H MR spectroscopy of human brain tumours: a practical approach. , 2008, European journal of radiology.

[51]  A. Haley,et al.  Dyslipidemia links obesity to early cerebral neurochemical alterations , 2013, Obesity.

[52]  J Kim,et al.  Imaging of the inflammatory response in reperfusion injury after transient cerebral ischemia in rats: correlation of superparamagnetic iron oxide-enhanced magnetic resonance imaging with histopathology , 2008, Acta radiologica.

[53]  H. Rusinek,et al.  MR spectroscopy indicates diffuse multiple sclerosis activity during remission , 2009, Journal of Neurology, Neurosurgery & Psychiatry.

[54]  M. Cybulsky,et al.  Getting to the site of inflammation: the leukocyte adhesion cascade updated , 2007, Nature Reviews Immunology.

[55]  D. Arnold,et al.  Dual‐temporal resolution dynamic contrast‐enhanced MRI protocol for blood–brain barrier permeability measurement in enhancing multiple sclerosis lesions , 2011, Journal of magnetic resonance imaging : JMRI.

[56]  A. Vezzani,et al.  In vivo imaging of glia activation using 1H‐magnetic resonance spectroscopy to detect putative biomarkers of tissue epileptogenicity , 2012, Epilepsia.

[57]  S. Hussain,et al.  Superparamagnetic iron oxide contrast agents: physicochemical characteristics and applications in MR imaging , 2001, European Radiology.

[58]  M. Viergever,et al.  Magnetic Resonance Imaging of Monocytes Labeled with Ultrasmall Superparamagnetic Particles of Iron Oxide Using Magnetoelectroporation in an Animal Model of Multiple Sclerosis , 2010, Molecular imaging.

[59]  A. van der Toorn,et al.  Dynamics and fate of USPIO in the central nervous system in experimental autoimmune encephalomyelitis , 2010, NMR in biomedicine.

[60]  Magnetic Resonance Spectroscopy to Assess NeuroInflammation and Neuropathic Pain , 2013, Journal of Neuroimmune Pharmacology.

[61]  Bruno Brochet,et al.  Early macrophage MRI of inflammatory lesions predicts lesion severity and disease development in relapsing EAE , 2006, NeuroImage.

[62]  David J. Begley,et al.  Structure and function of the blood–brain barrier , 2010, Neurobiology of Disease.

[63]  K. J. Brooks,et al.  Molecular Magnetic Resonance Imaging of Acute Vascular Cell Adhesion Molecule-1 Expression in a Mouse Model of Cerebral Ischemia , 2010, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[64]  Martin Bendszus,et al.  Cytokine profile of iron-laden macrophages: Implications for cellular magnetic resonance imaging , 2006, Journal of Neuroimmunology.

[65]  D. Brooks,et al.  Cerebral microglial activation in patients with hepatitis c: in vivo evidence of neuroinflammation , 2012, Journal of viral hepatitis.

[66]  M. Manns,et al.  Hepatitis C virus infection affects the brain-evidence from psychometric studies and magnetic resonance spectroscopy. , 2004, Journal of hepatology.

[67]  Olivier Beuf,et al.  MRI Monitoring of Neuroinflammation in Mouse Focal Ischemia , 2007, Stroke.

[68]  Axel Montagne,et al.  Ultra-sensitive molecular MRI of cerebrovascular cell activation enables early detection of chronic central nervous system disorders , 2012, NeuroImage.

[69]  E. Neuwelt,et al.  A physiological barrier distal to the anatomic blood-brain barrier in a model of transvascular delivery. , 1999, AJNR. American journal of neuroradiology.

[70]  N. Sibson,et al.  Glyconanoparticles allow pre-symptomatic in vivo imaging of brain disease , 2009, Proceedings of the National Academy of Sciences.

[71]  Ulrich Dirnagl,et al.  Tracking of systemically administered mononuclear cells in the ischemic brain by high-field magnetic resonance imaging , 2006, NeuroImage.

[72]  M. Knopp,et al.  Estimating kinetic parameters from dynamic contrast‐enhanced t1‐weighted MRI of a diffusable tracer: Standardized quantities and symbols , 1999, Journal of magnetic resonance imaging : JMRI.

[73]  H. D. de Vries,et al.  Comparison of SPIO and USPIO for in vitro labeling of human monocytes: MR detection and cell function. , 2007, Radiology.

[74]  H. Lanfermann,et al.  Evidence for neuroinflammation and neuroprotection in HCV infection-associated encephalopathy , 2010, Gut.

[75]  R. Dijkhuizen,et al.  MRI of Monocyte Infiltration in an Animal Model of Neuroinflammation Using SPIO-Labeled Monocytes or Free USPIO , 2008, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[76]  D. Häussinger,et al.  Expression of organic osmolyte transporters in cultured rat astrocytes and rat and human cerebral cortex. , 2014, Archives of biochemistry and biophysics.

[77]  Ralph Weissleder,et al.  Imaging of myeloperoxidase in mice by using novel amplifiable paramagnetic substrates. , 2006, Radiology.

[78]  John W. Chen,et al.  A paramagnetic contrast agent with myeloperoxidase-sensing properties. , 2006, Organic & biomolecular chemistry.

[79]  Ernst J. Rummeny,et al.  Different Capacity of Monocyte Subsets to Phagocytose Iron-Oxide Nanoparticles , 2011, PloS one.

[80]  Alan P Koretsky,et al.  MRI detection of single particles for cellular imaging. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[81]  Diana Anderson In Vitro Models , 1990, Drug safety.

[82]  Marco Prinz,et al.  Microglia and brain macrophages in the molecular age: from origin to neuropsychiatric disease , 2014, Nature Reviews Neuroscience.

[83]  Xueguo Liu,et al.  Magnetic resonance imaging of radiation-induced brain injury using targeted microparticles of iron oxide , 2012, Acta radiologica.

[84]  Steven P Sourbron,et al.  Classic models for dynamic contrast‐enhanced MRI , 2013, NMR in biomedicine.

[85]  R. Ransohoff,et al.  Development, maintenance and disruption of the blood-brain barrier , 2013, Nature Medicine.

[86]  A. MacKay,et al.  Is the magnetization transfer ratio a marker for myelin in multiple sclerosis? , 2011, Journal of magnetic resonance imaging : JMRI.

[87]  A. McAllister,et al.  Alterations in Immune Cells and Mediators in the Brain: It's Not Always Neuroinflammation! , 2014, Brain pathology.

[88]  P. Jacobs,et al.  Physical and chemical properties of superparamagnetic iron oxide MR contrast agents: ferumoxides, ferumoxtran, ferumoxsil. , 1995, Magnetic resonance imaging.

[89]  P Kochunov,et al.  Alterations in frontal white matter neurochemistry and microstructure in schizophrenia: implications for neuroinflammation , 2015, Translational Psychiatry.

[90]  P. Trouillas,et al.  Inflammatory Response After Ischemic Stroke: A USPIO-Enhanced MRI Study in Patients , 2007, Stroke.

[91]  Karen J. Ferguson,et al.  Willis on narcolepsy , 2003, Journal of neurology, neurosurgery, and psychiatry.

[92]  R. Weissleder,et al.  Distinguishing Inflammation from Tumor and Peritumoral Edema by Myeloperoxidase Magnetic Resonance Imaging , 2011, Clinical Cancer Research.

[93]  C. Robic,et al.  Magnetic iron oxide nanoparticles: synthesis, stabilization, vectorization, physicochemical characterizations, and biological applications. , 2008, Chemical reviews.

[94]  Daniel Pelletier,et al.  Evidence of elevated glutamate in multiple sclerosis using magnetic resonance spectroscopy at 3 T. , 2005, Brain : a journal of neurology.

[95]  Martin Bendszus,et al.  in Vivo Monitoring of Macrophage Infiltration in Experimental Ischemic Brain Lesions by Magnetic Resonance Imaging , 2003, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[96]  D. Vivien,et al.  Ultra-Sensitive Molecular MRI of Vascular Cell Adhesion Molecule-1 Reveals a Dynamic Inflammatory Penumbra After Strokes , 2013, Stroke.

[97]  Peter Mattsson,et al.  Metabolite concentrations in supraventricular white matter from teenage to early old age: A short echo time 1h magnetic resonance spectroscopy (MRS) study , 2010, Acta radiologica.

[98]  G Tedeschi,et al.  Brain atrophy and lesion load in a large population of patients with multiple sclerosis , 2005, Neurology.

[99]  B. Rosen,et al.  Evidence for brain glial activation in chronic pain patients. , 2015, Brain : a journal of neurology.

[100]  C. A. Shaw,et al.  In Vivo Mononuclear Cell Tracking Using Superparamagnetic Particles of Iron Oxide: Feasibility and Safety in Humans , 2012, Circulation Cardiovascular Imaging.

[101]  Christian Confavreux,et al.  Implementation of an Absolute Brain $^{1}$H-MRS Quantification Method to Assess Different Tissue Alterations in Multiple Sclerosis , 2012, IEEE Transactions on Biomedical Engineering.

[102]  Bertrand Tavitian,et al.  Noninvasive molecular imaging of neuroinflammation , 2012, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[103]  David F Kallmes,et al.  Intracranial Gadolinium Deposition after Contrast-enhanced MR Imaging. , 2015, Radiology.

[104]  A. Haley,et al.  Indirect Effects of Elevated Body Mass Index on Memory Performance Through Altered Cerebral Metabolite Concentrations , 2012, Psychosomatic medicine.

[105]  N. Sibson,et al.  Systemic Inflammatory Response Reactivates Immune-Mediated Lesions in Rat Brain , 2009, The Journal of Neuroscience.

[106]  Ponnada A Narayana,et al.  Magnetic Resonance Spectroscopy in the Monitoring of Multiple Sclerosis , 2005, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

[107]  Ralph Weissleder,et al.  Tracking the inflammatory response in stroke in vivo by sensing the enzyme myeloperoxidase , 2008, Proceedings of the National Academy of Sciences.

[108]  M. Rausch,et al.  MRI‐based monitoring of inflammation and tissue damage in acute and chronic relapsing EAE , 2003, Magnetic resonance in medicine.

[109]  R. Dijkhuizen,et al.  MRI of ICAM-1 Upregulation After Stroke: the Importance of Choosing the Appropriate Target-Specific Particulate Contrast Agent , 2013, Molecular Imaging and Biology.

[110]  Ofer Pasternak,et al.  In vivo imaging of neuroinflammation in schizophrenia , 2016, Schizophrenia Research.

[111]  Roland Martin,et al.  Magnetic resonance imaging of labeled T‐cells in a mouse model of multiple sclerosis , 2004, Annals of neurology.

[112]  Pascal J. Kieslich,et al.  Gadolinium retention in the dentate nucleus and globus pallidus is dependent on the class of contrast agent. , 2015, Radiology.

[113]  O. Garaschuk,et al.  Neuroinflammation in Alzheimer's disease , 2015, The Lancet Neurology.

[114]  C. Woolf,et al.  Neurogenic inflammation and the peripheral nervous system in host defense and immunopathology , 2012, Nature Neuroscience.

[115]  Y. Anzai,et al.  Blood-Brain Barrier Imaging and Therapeutic Potentials , 2006, Topics in magnetic resonance imaging : TMRI.

[116]  C. Moonen,et al.  Differential aquaporin 4 expression during edema build-up and resolution phases of brain inflammation , 2011, Journal of Neuroinflammation.

[117]  J Hennig,et al.  Proton magnetic resonance spectroscopy studies on human brain myo-inositol in hypo-osmolarity and hepatic encephalopathy. , 1994, Gastroenterology.

[118]  R. Weissleder,et al.  Demyelinating diseases: myeloperoxidase as an imaging biomarker and therapeutic target. , 2012, Radiology.

[119]  Assaf Tal,et al.  Serial proton MR spectroscopy of gray and white matter in relapsing-remitting MS , 2013, Neurology.